🧫
Tet2 modulation in Aβ42-injured mouse hippocampal neurons
active
experiment
Created: 2026-04-10T22:33:00
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-844b1c39-b8a4-4082-b3d4-947353c6b94a
🧫 Experiment Protocol
ExploratoryAlzheimer's diseaseTET2primary mouse hippocampal neuronsproposed
This in vitro experiment investigated the role of Ten eleven translocation-2 (Tet2) in protecting hippocampal neurons against amyloid-β42 oligomer-induced toxicity. Primary mouse hippocampal neurons were exposed to Aβ42 oligomers to create a model of neuronal injury. The researchers then used recombinant plasmids to either inhibit or overexpress Tet2 in these injured neurons. The study examined how modulating Tet2 expression levels affected neuronal survival and morphology under conditions of amyloid toxicity. Results showed that reduced Tet2 expression exacerbated neuronal damage, while increased Tet2 expression provided neuroprotection against Aβ42-induced toxicity.
PRIMARY OUTCOME
neuronal survival and morphology protection
EXPECTED OUTCOMES
1. The intervention targeting TET2 shifts neuronal survival and morphology protection in the predicted direction relative to the matched control arm.
2. Secondary disease-relevant readouts in Alzheimer's disease remain directionally concordant with the primary endpoint rather than showing isolated single-assay effects.
3. The effect persists after adjustment for baseline covariates, batch effects, or repeated-measures structure used in the study design.
SUCCESS CRITERIA
- Prespecified primary endpoint (neuronal survival and morphology protection) improves versus control with p < 0.05 or an equivalent corrected threshold used by the study.
- The effect size is biologically meaningful and reproduced across technical/biological replicates or the validation subset.
- Safety, data quality, and missingness remain within protocol-defined bounds so the result is interpretable rather than driven by attrition or assay failure.
PROTOCOL
1. Establish primary mouse hippocampal neurons cohorts for Alzheimer's disease and predefine inclusion, exclusion, and quality-control criteria before intervention. 2. Apply the experimental manipulation described for TET2, alongside matched control or comparator arms, and document dose, exposure window, and sample timing in a locked protocol log. 3. Measure neuronal survival and morphology protection together with orthogonal secondary readouts such as molecular, imaging, behavioral, or safety endpoints that are appropriate to the title and study design. 4. Use blinded outcome assessment where feasible, prespecified statistical analysis, and replicate the core readout across biological replicates or an independent validation subset. 5. Interpret results against the baseline study rationale: This in vitro experiment investigated the role of Ten eleven translocation-2 (Tet2) in protecting hippocampal neurons against amyloid-β42 oligomer-induced toxicity. Primary mouse hippocampal neurons were exposed to Aβ42 oligomers to create a model of neuronal
LINKED HYPOTHESES
h-d2722680· Epigenetic Memory Erasure via TET2 Activationh-d7121bcc· TET2-Mediated Demethylation Rejuvenation Therapyh-a90e2e89· Temporal TET2-Mediated Hydroxymethylation Cyclingh-bdbd2120· Gamma entrainment therapy to restore hippocampal-cortical synchronyh-seaad-51323624· Cell-Type Specific TREM2 Upregulation in DAM Microglia
Source: PMID 33165916 ↗
🧫 Experiment Extras
PATHWAY
DNA demethylation/epigenetic regulation
MARKET PRICE
$0.50
STATUS
proposed
Prediction Markets (1 direct, 0 via hypothesis — 1 total)
Gamma entrainment therapy to restore hippocampal-cortical synchronyYES 82% · Liq $100 · resolved▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.